Analysis of the efficacy and survival of ixazomib-containing regimens in patients with refractory and relapsed multiple myeloma

Saved in:
Bibliographic Details
Published in:Zhōnghuá xuèyèxué zázhì 2022-08, Vol.43 (8), p.680
Main Authors: Yang, C, Zhuang, J L
Format: Article
Language:Chinese
Subjects:
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Boron Compounds - therapeutic use
Dexamethasone - therapeutic use
Glycine - therapeutic use
Humans
Lenalidomide - therapeutic use
Multiple Myeloma - drug therapy
Neoplasm Recurrence, Local - drug therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0253-2727
DOI:10.3760/cma.j.issn.0253-2727.2022.08.011